Announced today, ALTURiX – a new British company – has conditionally acquired the rights to a portfolio of well-known medicines which are prescribed widely by the NHS. The mission set out by the founders of the new company is to reliably provide branded products at an appropriate price. ALTURiX has been created and shaped to provide these high quality medicines to the NHS with streamlined efficiency. The company portfolio includes three heritage, branded products acquired from Novartis – all proven and acknowledged to improve patients’ health. ALTURiX will continue to reliably supply these products to the NHS and other international markets, using its high-quality manufacturing partner based in Switzerland. This is in keeping with the company’s commitment to reliably deliver high-quality products, at a sensible price.
Contact: Lak Sahota
Telephone: +44 (0)1908 038090